Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway / 中草药·英文版
Chinese Herbal Medicines
;
(4): 111-116, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-953612
ABSTRACT
Objective:
To investigate the potential effect of Lysimachia capillipes capilliposide (LCC) on the chemo sensitivity and the stemness of human ovarian cancer cells.Methods:
Cell Counting Kit-8 (CCK8) was used to measure the IC
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Herbal Medicines
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS